# Remimazolam and Endovascular Procedures of Cerebrovascular Diseases

> **NCT04950621** · NA · COMPLETED · sponsor: **Air Force Military Medical University, China** · enrollment: 142 (actual)

## Conditions studied

- Cerebrovascular Disorders
- Anesthesia

## Interventions

- **DRUG:** remimazolam
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT04950621
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-13
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2022-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04950621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04950621, "Remimazolam and Endovascular Procedures of Cerebrovascular Diseases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04950621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*